RAFAEL HOLDINGS, INC. Payments to Acquire Available-for-sale Securities, Equity
RAFAEL HOLDINGS, INC. (RFL) reported Payments to Acquire Available-for-sale Securities, Equity of $7.50 million for the 12-month period ending 2021-07-31, per its 10-K filed 2021-10-18.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity · last filed 2021-10-18
- RAFAEL HOLDINGS, INC. payments to acquire available-for-sale securities, equity for the quarter ending 2021-07-31 was $3.75M.
- RAFAEL HOLDINGS, INC. payments to acquire available-for-sale securities, equity for the quarter ending 2021-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. payments to acquire available-for-sale securities, equity for the quarter ending 2021-01-31 was $1.88M.
- RAFAEL HOLDINGS, INC. payments to acquire available-for-sale securities, equity for the quarter ending 2020-10-31 was $1.88M.
- RAFAEL HOLDINGS, INC. payments to acquire available-for-sale securities, equity for fiscal 2021 was $7.50M.
| Period end | Payments to Acquire Available-for-sale Securities, Equity 3 month | Payments to Acquire Available-for-sale Securities, Equity 6 month | Payments to Acquire Available-for-sale Securities, Equity 9 month | Payments to Acquire Available-for-sale Securities, Equity 12 month |
|---|---|---|---|---|
| 2021-07-31 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | $3.75M derived: sum of 2 quarters · filed 2021-10-18 | $5.63M derived: sum of 3 quarters · filed 2021-10-18 | $7.50M 10-K · filed 2021-10-18 |
| 2021-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-06-14 | $1.88M derived: sum of 2 quarters · filed 2021-06-14 | $3.75M 10-Q · filed 2021-06-14 | |
| 2021-01-31 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-03-17 | $3.75M 10-Q · filed 2021-03-17 | ||
| 2020-10-31 | $1.88M 10-Q · filed 2020-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |